These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 37521857)

  • 1. Picomolar inhibitor of reverse transcriptase featuring significantly improved metabolic stability.
    Sang YL; Pannecouque C; De Clercq E; Wang S; Chen FE
    Acta Pharm Sin B; 2023 Jul; 13(7):3054-3066. PubMed ID: 37521857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging roles of Aurora-A kinase in cancer therapy resistance.
    Zheng D; Li J; Yan H; Zhang G; Li W; Chu E; Wei N
    Acta Pharm Sin B; 2023 Jul; 13(7):2826-2843. PubMed ID: 37521867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel mesenchymal stem cell-based regimen for acute myeloid leukemia differentiation therapy.
    Sun L; Yang N; Chen B; Bei Y; Kang Z; Zhang C; Zhang N; Xu P; Yang W; Wei J; Ke J; Sun W; Li X; Shen P
    Acta Pharm Sin B; 2023 Jul; 13(7):3027-3042. PubMed ID: 37521858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversing the PAI-1-induced fibrotic immune exclusion of solid tumor by multivalent CXCR4 antagonistic nano-permeator.
    Dong J; Zhu C; Huang Y; Li Q; Li J; Wang Z; Wang Y; Zhou Z; Sun M
    Acta Pharm Sin B; 2023 Jul; 13(7):3106-3120. PubMed ID: 37521859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phototriggered structures: Latest advances in biomedical applications.
    Shamsipur M; Ghavidast A; Pashabadi A
    Acta Pharm Sin B; 2023 Jul; 13(7):2844-2876. PubMed ID: 37521863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GPRC5B protects osteoarthritis by regulation of autophagy signaling.
    He L; Xu Z; Niu X; Li R; Wang F; You Y; Gao J; Zhao L; Shah KM; Fan J; Liu M; Luo J
    Acta Pharm Sin B; 2023 Jul; 13(7):2976-2989. PubMed ID: 37521864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral origin exosomal microRNAs aggravate glymphatic system dysfunction in diabetic cognitive impairment.
    Zhang L; Li D; Yi P; Shi J; Guo M; Yin Q; Liu D; Zhuang P; Zhang Y
    Acta Pharm Sin B; 2023 Jul; 13(7):2817-2825. PubMed ID: 37521866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of insulin-like growth factor-1 receptor (IGF-1R) promotes growth of colorectal cancer through triggering the MEX3A-mediated degradation of RIG-I.
    Xie Q; Chu Y; Yuan W; Li Y; Li K; Wu X; Liu X; Xu R; Cui S; Qu X
    Acta Pharm Sin B; 2023 Jul; 13(7):2963-2975. PubMed ID: 37521868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erratum to "Identification of anti-
    Zhang H; Chen Y; Zhang Y; Qiao L; Chi X; Han Y; Lin Y; Si S; Jiang J
    Acta Pharm Sin B; 2023 Jul; 13(7):3180. PubMed ID: 37521869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutamate-releasing BEST1 channel is a new target for neuroprotection against ischemic stroke with wide time window.
    Xiong S; Xiao H; Sun M; Liu Y; Gao L; Xu K; Liang H; Jiang N; Lin Y; Chang L; Wu H; Zhu D; Luo C
    Acta Pharm Sin B; 2023 Jul; 13(7):3008-3026. PubMed ID: 37521872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A rationally designed cancer vaccine based on NIR-II fluorescence image-guided light-triggered remote control of antigen cross-presentation and autophagy.
    Wu A; Yang A; Tong Q; Wei G; Zhang S; Yu S; Zhang C; Xu J; Lu W
    Acta Pharm Sin B; 2023 Jul; 13(7):3121-3136. PubMed ID: 37521873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Newly developed gas-assisted sonodynamic therapy in cancer treatment.
    Pan M; Hu D; Yuan L; Yu Y; Li Y; Qian Z
    Acta Pharm Sin B; 2023 Jul; 13(7):2926-2954. PubMed ID: 37521874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isotoosendanin exerts inhibition on triple-negative breast cancer through abrogating TGF-
    Zhang J; Zhang Z; Huang Z; Li M; Yang F; Wu Z; Guo Q; Mei X; Lu B; Wang C; Wang Z; Ji L
    Acta Pharm Sin B; 2023 Jul; 13(7):2990-3007. PubMed ID: 37521871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erratum: Author correction to "YPD-30, a prodrug of YPD-29B, is an oral small-molecule inhibitor targeting PD-L1 for the treatment of human cancer" [Acta Pharmaceutica Sinica B 12 (2022) 2845-2858].
    Lai F; Ji M; Huang L; Wang Y; Xue N; Du T; Dong K; Yao X; Jin J; Feng Z; Chen X
    Acta Pharm Sin B; 2023 Jul; 13(7):3178-3179. PubMed ID: 37521865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acid-switchable nanoparticles induce self-adaptive aggregation for enhancing antitumor immunity of natural killer cells.
    Sun X; Xu X; Wang J; Zhang X; Zhao Z; Liu X; Wang G; Teng L; Chen X; Wang D; Li Y
    Acta Pharm Sin B; 2023 Jul; 13(7):3093-3105. PubMed ID: 37521862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deubiquitination complex platform: A plausible mechanism for regulating the substrate specificity of deubiquitinating enzymes.
    Fang YZ; Jiang L; He Q; Cao J; Yang B
    Acta Pharm Sin B; 2023 Jul; 13(7):2955-2962. PubMed ID: 37521861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A redox-responsive self-assembling COA-4-arm PEG prodrug nanosystem for dual drug delivery suppresses cancer metastasis and drug resistance by downregulating hsp90 expression.
    Zhou Y; Miao Y; Huang Q; Shi W; Xie J; Lin J; Huang P; Yue C; Qin Y; Yu X; Wang H; Qin L; Chen J
    Acta Pharm Sin B; 2023 Jul; 13(7):3153-3167. PubMed ID: 37521875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution and development of potent monobactam sulfonate candidate IMBZ18g as a dual inhibitor against MDR Gram-negative bacteria producing ESBLs.
    Li Z; Guo Z; Lu X; Ma X; Wang X; Zhang R; Hu X; Wang Y; Pang J; Fan T; Liu Y; Tang S; Fu H; Zhang J; Li Y; You X; Song D
    Acta Pharm Sin B; 2023 Jul; 13(7):3067-3079. PubMed ID: 37521870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlling antifungal activity with light: Optical regulation of fungal ergosterol biosynthetic pathway with photo-responsive CYP51 inhibitors.
    Li Z; Liu N; Yang W; Tu J; Huang Y; Wang W; Sheng C
    Acta Pharm Sin B; 2023 Jul; 13(7):3080-3092. PubMed ID: 37521860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-Cyano substituted diarylpyridines as potent HIV-1 NNRTIs: Rational design, synthesis, and activity evaluation.
    Song H; Xia Y; Zhang T; Dun C; Meng B; De Clercq E; Pannecouque C; Kang D; Zhan P; Liu X
    Eur J Med Chem; 2023 Nov; 259():115686. PubMed ID: 37536208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.